Iron homeostasis and inherited iron overload disorders: An overview

Hematology/Oncology Clinics of North America

Volumn 18, Issue 6 SPEC.ISS., 2004, Pages 1379-1403

  Heeney, Matthew M ^a,b   Andrews, Nancy C ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; CERULOPLASMIN; CYTOSINE; FERRITIN; FERROPORTIN 1; HEMOJUVELIN; HEMOSIDERIN; HEPCIDIN; HISTIDINE; IRON; IRON BINDING PROTEIN; PROTEIN; TRANSFERRIN; TRANSFERRIN RECEPTOR; TYROSINE; UNCLASSIFIED DRUG;

ACERULOPLASMINEMIA; AFRICAN SIDEROSIS; AMINO ACID SUBSTITUTION; CHROMOSOME 1Q; CHROMOSOME 3Q; CHROMOSOME 6P; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE MARKER; ERYTHROCYTE; ERYTHROPOIESIS; FERROPORTIN DISEASE; GENE MUTATION; GENETIC DISORDER; GENETIC SCREENING; HEMOCHROMATOSIS; HEMOSIDEROSIS; HEREDITY; HETEROZYGOSITY; HOMEOSTASIS; HOMOZYGOSITY; HUMAN; INTESTINE CELL; INTESTINE MUCOSA; IRON ABSORPTION; IRON BALANCE; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON CHELATION; IRON KINETICS; IRON METABOLISM; IRON OVERLOAD; IRON STORAGE; IRON TRANSPORT; JUVENILE HEMOCHROMATOSIS; LIVER BIOPSY; LIVER CELL; LIVER CIRRHOSIS; LIVER FAILURE; MACROPHAGE; MASS SCREENING; MELANOSIS; MISSENSE MUTATION; NEONATAL HEMOCHROMATOSIS; NONSENSE MUTATION; ONSET AGE; PHAGOCYTOSIS; PHENOTYPE; PHLEBOTOMY; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; REVIEW; TRANSFERRIN DEFICIENCY; TYPE 3 HEMOCHROMATOSIS;

EID: 7044260686     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2004.06.018     Document Type: Review

References (102)

1. J.D. Cook, W.E. Barry, C. Hershko, G. Fillet, and C.A. Finch Iron kinetics with emphasis on iron overload Am J Pathol 72 2 1973 337 343
2. A.T. McKie, G.O. Latunde-Dada, S. Miret, J.A. McGregor, G.J. Anderson, and C.D. Vulpe Molecular evidence for the role of a ferric reductase in iron transport Biochem Soc Trans 30 4 2002 722 724
3. H. Gunshin, B. Mackenzie, U.V. Berger, Y. Gunshin, M.F. Romero, and W.F. Boron Cloning and characterization of a mammalian proton-coupled metal-ion transporter Nature 388 1997 482 488
4. M.D. Fleming, C.C. Trenor, M.A. Su, D. Foernzler, B.R. Beier, and W.F. Dietrich Microcytic anemia mice have a mutation in Nramp2, a candidate iron transporter gene Nat Genet 16 1997 383 386
5. A. Donovan, A. Brownlie, Y. Zhou, J. Shepard, S.J. Pratt, and J. Moynihan Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter Nature 403 6771 2000 776 781
6. A.T. McKie, P. Marciani, A. Rolfs, K. Brennan, K. Wehr, and D. Barrow A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation Mol Cell 5 2000 299 309
7. S. Abboud, and D.J. Haile A novel mammalian iron-regulated protein involved in intracellular iron metabolism J Biol Chem 275 2000 19906 19912
8. H. Chen, Z.K. Attieh, T. Su, B.A. Syed, H. Gao, and R.M. Alaeddine Hephaestin is a ferroxidase that maintains partial activity in sex linked anemia mice Blood 103 10 2004 3933 3939
9. G. Nicolas, M. Bennoun, A. Porteu, S. Mativet, C. Beaumont, and B. Grandchamp Severe iron deficiency anemia in transgenic mice expressing liver hepcidin Proc Natl Acad Sci U S A 99 7 2002 4596 4601
10. G. Nicolas, M. Bennoun, I. Devaux, C. Beaumont, B. Grandchamp, and A. Kahn Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice Proc Natl Acad Sci USA 98 15 2001 8780 8785
11. G. Nicolas, C. Chauvet, L. Viatte, J.L. Danan, X. Bigard, and I. Devaux The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation J Clin Invest 110 7 2002 1037 1044
12. M.W. Hentze, M. Muckenthaler, and N.C. Andrews Balancing acts: molecular control of iron metabolism Cell 117 3 2004 285 297
13. A. Dautry-Varsat, A. Ciechanover, and H.F. Lodish pH and the recycling of transferrin during receptor-mediated endocytosis Proc Natl Acad Sci USA 80 1983 2258 2262
14. D.M. Sipe, and R.F. Murphy Binding to cellular receptors results in increased iron release from transferrin at mildly acidic pH J Biol Chem 266 1991 8002 8007
15. M.D. Fleming, M.A. Romano, M.A. Su, L.M. Garrick, M.D. Garrick, and N.C. Andrews Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport Proc Natl Acad Sci U S A 95 3 1998 1148 1153
16. C.H. Park, E.V. Valore, A.J. Waring, and T. Ganz Hepcidin, a urinary antimicrobial peptide synthesized in the liver J Biol Chem 276 11 2001 7806 7810
17. P.F. Hahn, W.F. Bale, J.F. Ross, W.M. Balfour, and G.H. Whipple Radioactive iron absorption by the gastronintestinal tract: influence of anemia, anoxia, and antecedent feeding J Exp Med 78 1943 169 188
18. C. Finch Regulators of iron balance in humans Blood 84 1994 1697 1702
19. C. Pigeon, G. Ilyin, B. Courselaud, P. Leroyer, B. Turlin, and P. Brissot A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload J Biol Chem 276 11 2001 7811 7819
20. E. Nemeth, S. Rivera, V. Gabayan, C. Keller, S. Taudorf, and B.K. Pedersen Interleukin-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron-regulatory hormone hepcidin J Clin Invest 113 9 2004 1271 1276
21. D.A. Weinstein, C.N. Roy, M.D. Fleming, M.F. Loda, J.I. Wolfsdorf, and N.C. Andrews Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease Blood 100 10 2002 3776 3781
22. E. Nemeth, E.V. Valore, M. Territo, G. Schiller, A. Lichtenstein, and T. Ganz Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein Blood 101 7 2003 2461 2463
23. E.D. Weinberg Iron depletion: a defense against intracellular infection and neoplasia Life Sci 50 1992 1289 1297
24. A. Roetto, G. Papanikolaou, M. Politou, F. Alberti, D. Girelli, and J. Christakis Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis Nat Genet 33 1 2003 21 22
25. G. Papanikolaou, M.E. Samuels, E.H. Ludwig, M.L. MacDonald, P.L. Franchini, and M.P. Dube Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis Nat Genet 36 1 Jan 2004 77 82
26. A. Trousseau Glycosurie; diabete sucre [Glucosuria; sugar diabetes] Clinique medicale de l'Hotel-Dieu de Paris 2 1865 663 698 [in French]
27. R.S. Ajioka, L.B. Jorde, J.R. Gruen, D. Dimitrova, J. Barrow, and E. Radisky Haplotype analysis of hemochromatosis: evaluation of different linkage-disequilibrium approaches and evolution of disease chromosomes Am J Hum Genet 60 1997 1439 1447
28. M. Simon, M. Bourel, R. Fauchet, and B. Genetet Association of HLA-A3 and HLA-B14 antigens with idiopathic haemochromatosis Gut 17 1976 332 334
29. J.N. Feder, A. Gnirke, W. Thomas, Z. Tsuchihashi, D.A. Ruddy, and A. Basava A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis Nat Genet 13 1996 399 408
30. J.A. Lebron, M.J. Bennett, D.E. Vaughn, A.J. Chirino, P.M. Snow, and G.A. Mintier Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor Cell 93 1998 111 123
31. J.A. Lebron, A.P. West Jr, and P.J. Bjorkman The hemochromatosis protein HFE competes with transferrin for binding to the transferrin receptor J Mol Biol 294 1 1999 239 245
32. K.R. Bridle, D.M. Frazer, S.J. Wilkins, J.L. Dixon, D.M. Purdie, and D.H. Crawford Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis Lancet 361 9358 2003 669 673
33. J.K. Olynyk, D.J. Cullen, S. Aquilia, E. Rossi, L. Summerville, and L.W. Powell A population-based study of the clinical expression of the hemochromatosis gene N Engl J Med 341 10 1999 718 724
34. R.S. Ajioka, and J.P. Kushner Clinical consequences of iron overload in hemochromatosis homozygotes Blood 101 9 2003 3351 3353
35. E. Beutler The HFE cys282Tyr mutation as a necessary but not sufficient cause of clinical hereditary hemochromatosis Blood 101 9 2003 3347 3350
36. A.T. Merryweather-Clarke, J.J. Pointon, J.D. Shearman, and K.J. Robson Global prevalence of putative haemochromatosis mutations J Med Genet 34 4 1997 275 278
37. J.C. Barton, R. Sawada-Hirai, B.E. Rothenberg, and R.T. Acton Two novel missense mutations of the HFE gene (I105T and G93R) and identification of the S65C mutation in Alabama hemochromatosis probands Blood Cells Mol Dis 25 3-4 1999 147 155
38. C. Mura, O. Raguenes, and C. Ferec HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis Blood 93 8 1999 2502 2505
39. D.F. Wallace, J.S. Dooley, and A.P. Walker A novel mutation of HFE explains the classical phenotype of genetic hemochromatosis in a C282Y heterozygote Gastroenterology 116 6 1999 1409 1412
40. A.T. Merryweather-Clarke, E. Cadet, A. Bomford, D. Capron, V. Viprakasit, and A. Miller Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis Hum Mol Genet 12 17 2003 2241 2247
41. C. Lanzara, A. Roetto, F. Daraio, S. Rivard, R. Ficarella, and H. Simard The spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis Blood 103 11 2004 4317 4321
42. P.P. Monnier, A. Sierra, P. Macchi, L. Deitinghoff, J.S. Andersen, and M. Mann RGM is a repulsive guidance molecule for retinal axons Nature 419 6905 2002 392 395
43. M. De Gobbi, A. Roetto, A. Piperno, R. Mariani, F. Alberti, and G. Papanikolaou Natural history of juvenile haemochromatosis Br J Haematol 117 4 2002 973 979
44. A. Pietrangelo Non-HFE hemochromatosis Hepatology 39 1 2004 21 29
45. A.P. West Jr, M.J. Bennett, V.M. Sellers, N.C. Andrews, C.A. Enns, and P.J. Bjorkman Comparison of the interactions of transferrin receptor and transferrin receptor 2 with transferrin and the hereditary hemochromatosis protein HFE J Biol Chem 275 49 2000 38135 38138
46. C. Camaschella, A. Roetto, A. Cali, M. De Gobbi, G. Garozzo, and M. Carella The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22 Nat Genet 25 2000 14 15
47. A. Roetto, A. Totaro, A. Piperno, A. Piga, F. Longo, and G. Garozzo New mutations inactivating transferrin receptor 2 in hemochromatosis type 3 Blood 97 9 2001 2555 2560
48. A. Mattman, D. Huntsman, G. Lockitch, S. Langlois, N. Buskard, and D. Ralston Transferrin receptor 2 (TfR2) and HFE mutational analysis in non-C282Y iron overload: identification of a novel TfR2 mutation Blood 100 3 2002 1075 1077
49. A. Hattori, S. Wakusawa, H. Hayashi, A. Harashima, F. Sanae, and M. Kawanaka AVAQ 594-597 deletion of the TfR2 gene in a Japanese family with hemochromatosis Hepatol Res 26 2 2003 154 156
50. D. Girelli, C. Bozzini, A. Roetto, F. Alberti, F. Daraio, and R. Colombari Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in transferrin receptor 2 gene Gastroenterology 122 5 2002 1295 1302
51. S. Goldfischer, H.W. Grotsky, C.H. Chang, E.L. Berman, R.R. Richert, and S.D. Karmarkar Idiopathic neonatal iron storage involving the liver, pancreas, heart, and endocrine and exocrine glands Hepatology 1 1 1981 58 64
52. A.S. Knisely Neonatal hemochromatosis Adv Pediatr 39 1992 383 403
53. K.F. Murray, and K.V. Kowdley Neonatal hemochromatosis Pediatrics 108 4 2001 960 964
54. M.M. Silver, D.W. Beverley, L.S. Valberg, E. Cutz, M.J. Phillips, and W.A. Shaheed Perinatal hemochromatosis. Clinical, morphologic, and quantitative iron studies Am J Pathol 128 3 1987 538 554
55. T.M. Cox, and D.J. Halsall Hemochromatosis-neonatal and young subjects Blood Cells Mol Dis 29 3 2002 411 417
56. A.L. Kelly, P.W. Lunt, F. Rodrigues, P.J. Berry, D.M. Flynn, and P.J. McKiernan Classification and genetic features of neonatal haemochromatosis: a study of 27 affected pedigrees and molecular analysis of genes implicated in iron metabolism J Med Genet 38 9 2001 599 610
57. A.S. Knisely, G. Mieli-Vergani, and P.F. Whitington Neonatal hemochromatosis Gastroenterol Clin North Am 32 3 2003 877 889
58. A. Verloes, I.K. Temple, A.F. Hubert, P. Hope, S. Gould, and C. Debauche Recurrence of neonatal haemochromatosis in half sibs born of unaffected mothers J Med Genet 33 6 1996 444 449
59. A.M. Hayes, D. Jaramillo, H.L. Levy, and A.S. Knisely Neonatal hemochromatosis: diagnosis with MR imaging AJR Am J Roentgenol 159 3 1992 623 625
60. D.M. Flynn, N. Mohan, P. McKiernan, S. Beath, J. Buckels, and D. Mayer Progress in treatment and outcome for children with neonatal haemochromatosis Arch Dis Child Fetal Neonatal Ed 88 2 2003 F124 F127
61. A. Pietrangelo The ferroportin disease Blood Cells Mol Dis 32 1 2004 131 138
62. O.T. Njajou, N. Vaessen, M. Joosse, B. Berghuis, J.W. van Dongen, and M.H. Breuning A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis Nat Genet 28 3 2001 213 214
63. G. Montosi, A. Donovan, A. Totaro, C. Garuti, E. Pignatti, and S. Cassanelli Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene J Clin Invest 108 4 2001 619 623
64. O.T. Njajou, G. de Jong, B. Berghuis, N. Vaessen, P.J. Snijders, and J.P. Goossens Dominant hemochromatosis due to N144H mutation of SLC11A3: clinical and biological characteristics Blood Cells Mol Dis 29 3 2002 439 443
65. V.R. Gordeuk, A. Caleffi, E. Corradini, F. Ferrara, R.A. Jones, and O. Castro Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene Blood Cells Mol Dis 31 3 2003 299 304
66. E. Beutler, J.C. Barton, V.J. Felitti, T. Gelbart, C. West, and P.L. Lee Ferroportin 1 (SCL40A1) variant associated with iron overload in African-Americans Blood Cells Mol Dis 31 3 2003 305 309
67. B.N. Patel, and S. David A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes J Biol Chem 272 32 1997 20185 20190
68. L.W. Klomp, and J.D. Gitlin Expression of the ceruloplasmin gene in the human retina and brain: implications for a pathogenic model in aceruloplasminemia Hum Mol Genet 5 12 1996 1989 1996
69. S. Osaki, D.A. Johnson, and E. Frieden The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum J Biol Chem 241 12 1966 2746 2751
70. S. Osaki, and D.A. Johnson Mobilization of liver iron by ferroxidase (ceruloplasmin) J Biol Chem 244 20 1969 5757 5758
71. K. Yoshida, K. Furihata, S. Takeda, A. Nakamura, K. Yamamoto, and H. Morita A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans Nat Genet 9 3 1995 267 272
72. Z.L. Harris, Y. Takahashi, H. Miyajima, M. Serizawa, R.T. MacGillivray, and J.D. Gitlin Aceruloplasminemia: molecular characterization of this disorder of iron metabolism Proc Natl Acad Sci USA 92 7 1995 2539 2543
73. H. Miyajima, Y. Nishimura, K. Mizoguchi, M. Sakamoto, T. Shimizu, and N. Honda Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration Neurology 37 5 1987 761 767
74. H. Miyajima, Y. Takahashi, and S. Kono Aceruloplasminemia, an inherited disorder of iron metabolism Biometals 16 1 2003 205 213
75. H. Miyajima Aceruloplasminemia, an iron metabolic disorder Neuropathology 23 4 2003 345 350
76. H. Miyajima, Y. Takahashi, T. Kamata, H. Shimizu, N. Sakai, and J.D. Gitlin Use of desferrioxamine in the treatment of aceruloplasminemia Ann Neurol 41 3 1997 404 407
77. O. Loreal, B. Turlin, C. Pigeon, A. Moisan, M. Ropert, and P. Morice Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights J Hepatol 36 6 2002 851 856
78. M. Yonekawa, T. Okabe, Y. Asamoto, and M. Ohta A case of hereditary ceruloplasmin deficiency with iron deposition in the brain associated with chorea, dementia, diabetes mellitus and retinal pigmentation: administration of fresh-frozen human plasma Eur Neurol 42 3 1999 157 162
79. E. Beutler, T. Gelbart, P. Lee, R. Trevino, M.A. Fernandez, and V.F. Fairbanks Molecular characterization of a case of atransferrinemia Blood 96 13 2000 4071 4074
80. L. Heilmeyer, W. Keller, O. Vivell, W. Keiderling, K. Betke, and F. Wohler Congenital transferrin deficiency in a seven-year old girl Ger Med Mon 86 1961 1745 1751
81. N. Goya, S. Miyazaki, S. Kodate, and B. Ushio A family of congenital atransferrinemia Blood 40 1972 239 245
82. R.L. Hamill, J.C. Woods, and B.A. Cook Congenital atransferrinemia: a case report and review of the literature Am J Clin Pathol 96 1991 215 218
83. J.C. Barton, S.M. McDonnell, P.C. Adams, P. Brissot, L.W. Powell, and C.Q. Edwards Management of hemochromatosis. Hemochromatosis Management Working Group Ann Intern Med 129 11 1998 932 939
84. G.M. Brittenham, P.M. Griffith, A.W. Nienhuis, C.E. McLaren, N.S. Young, and E.E. Tucker Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major N Engl J Med 331 9 1994 567 573
85. E. Angelucci, P. Muretto, A. Nicolucci, D. Baronciani, B. Erer, and J. Gaziev Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation Blood 100 1 2002 17 21
86. M.L. Bassett, J.W. Halliday, and L.W. Powell Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis Hepatology 6 1 1986 24 29
87. J.S. Dooley Diagnosis and management of genetic haemochromatosis Best Pract Res Clin Haematol 15 2 2002 277 293
88. British Committee for Standards in Haematology Guidelines on diagnosis and treatment. Genetic haemochromatosis Available at: www.bcshguidelines.com/ (under General Haematology. Accessed April 2004)
89. D. Guyader, C. Jacquelinet, R. Moirand, B. Turlin, M.H. Mendler, and J. Chaperon Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis Gastroenterology 115 4 1998 929 936
90. G.M. Brittenham, G. Weiss, P. Brissot, F. Laine, A. Guillygomarc'h, and D. Guyader Clinical consequences of new insights in the pathophysiology of disorders of iron and heme metabolism Hematology (Am Soc Hematol Educ Program) 2000 39 50
91. J.M. Alustiza, J. Artetxe, A. Castiella, C. Agirre, J.I. Emparanza, and P. Otazua MR quantification of hepatic iron concentration Radiology 230 2 2004 479 484
92. H.L. Bonkovsky, R.B. Rubin, E.E. Cable, A. Davidoff, T.H. Rijcken, and D.D. Stark Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques Radiology 212 1 1999 227 234
93. Canadian Paediatric Society (Bioethics Committee) Guidelines for genetic testing of healthy children. Position Statement (B 2003-01) Available at: http://www.cps.ca/english/statements/B/b03-01.htm Accessed April 2004
94. R.M. Nelson, J.R. Botkjin, E.D. Kodish, M. Levetown, J.T. Truman, and B.S. Wilfond A.A.P. Committee on Bioethics: ethical issues with genetic testing in pediatrics Pediatrics 107 6 2001 1451 1455
95. American Medical Association Code of Medical Ethics, Policy E-2.138: Genetic Testing of Children. July 22, 2002 Available at: http://www.ama-assn. org/ama/pub/category/print/8439.html Accessed April 2004
96. M.J. Khoury, L.L. McCabe, and E.R. McCabe Population screening in the age of genomic medicine N Engl J Med 348 1 2003 50 58
97. W.D. Davis, and W.R. Arrowsmith The effect of repeated bleeding in hemochromatosis J Lab Clin Med 36 1950 814 815
98. W.H. Crosby A history of phlebotomy therapy for hemochromatosis Am J Med Sci 301 1 1991 28 31
99. C.D. Bolan, C. Conry-Cantilena, G. Mason, T.A. Rouault, and S.F. Leitman MCV as a guide to phlebotomy therapy for hemochromatosis Transfusion 41 6 2001 819 827
100. J.C. Barton, and S.S. Bottomley Iron deficiency due to excessive therapeutic phlebotomy in hemochromatosis Am J Hematol 65 3 2000 223 226
101. A. Maggio, G. D'Amico, A. Morabito, M. Capra, C. Ciaccio, and P. Cianciulli Deferiprone versus deferoxamine in patients with thalassemia major: a randomized clinical trial Blood Cells Mol Dis 28 2 2002 196 208
102. H. Nick, P. Acklin, R. Lattmann, P. Buehlmayer, S. Hauffe, and J. Schupp Development of tridentate iron chelators: from desferrithiocin to ICL670 Curr Med Chem 10 12 2003 1065 1076